Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
The "Stroke - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets.com's offering.The clinical trial report provides an overview of Stroke Clinical trials scenario ...
Phase III PRESTIGE-AF trial shows that direct oral anticoagulants significantly lower the risk of ischemic stroke in ...
In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
A pivotal study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
News Medical on MSN4h
Research identifies iron as crucial driver of stroke-related cell death processesIschemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
Among stroke survivors, the risk of developing dementia after stroke is significantly high, highlighting the need for targeted prevention strategies.
The FDA said to stop all use of Philips' Tack Endovascular System, which is under class I recall for user difficulties in ...
DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for severe ischemic diseases, today announced the peer-reviewed ...
The U.S. Environment Protection Agency has completed Phase 1 of the hazardous debris removal process in the Los Angeles ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback